120 related articles for article (PubMed ID: 16584388)
1. Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.
Fishman S; Lurie Y; Peretz H; Morad T; Grynberg E; Blendis LM; Leshno M; Brazowski E; Rosner G; Halpern Z; Oren R
Liver Int; 2006 Apr; 26(3):279-84. PubMed ID: 16584388
[TBL] [Abstract][Full Text] [Related]
2. [Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers].
Samokhodskaia LM; Starostina EE; Yarovaya EB; Krasnova TN; Mukhin NA; Tkachuk VA; Sadovnichy VA
Vestn Ross Akad Med Nauk; 2015; (6):651-61. PubMed ID: 27093792
[TBL] [Abstract][Full Text] [Related]
3. IL17A gene polymorphisms: relationship to predisposition for chronic viral hepatitis and progression to liver cirrhosis in kazakh population.
Massabayeva MR; Aukenov NE; Mussazhanova ZB; Saenko VA; Rogounovitch TI; Shaimardanov NK; Kurmanova BR; Barkibaeva NR; Rakhypbekov TK
Vopr Virusol; 2016; 61(5):212-9. PubMed ID: 29323853
[TBL] [Abstract][Full Text] [Related]
4. The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients.
Nischalke HD; Berger C; Luda C; Müller T; Berg T; Coenen M; Krämer B; Körner C; Trebicka J; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U
J Hepatol; 2012 Apr; 56(4):758-64. PubMed ID: 22173151
[TBL] [Abstract][Full Text] [Related]
5. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
6. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
Carrión JA; Torres F; Crespo G; Miquel R; García-Valdecasas JC; Navasa M; Forns X
Hepatology; 2010 Jan; 51(1):23-34. PubMed ID: 19839063
[TBL] [Abstract][Full Text] [Related]
7. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.
Maharshak N; Halfon P; Deutsch V; Peretz H; Berliner S; Fishman S; Zelber-Sagi S; Rozovski U; Leshno M; Oren R
World J Gastroenterol; 2011 Dec; 17(45):5007-13. PubMed ID: 22174551
[TBL] [Abstract][Full Text] [Related]
8. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
Abu Dayyeh BK; Yang M; Fuchs BC; Karl DL; Yamada S; Sninsky JJ; O'Brien TR; Dienstag JL; Tanabe KK; Chung RT;
Gastroenterology; 2011 Jul; 141(1):141-9. PubMed ID: 21440548
[TBL] [Abstract][Full Text] [Related]
9. The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.
Zimmermann T; Hoppe-Lotichius M; Körner A; Lautem A; Heise M; Foltys D; Weiler N; Biesterfeld S; Schmidtmann I; Galle PR; Otto G; Schuchmann M
Transpl Int; 2011 Nov; 24(11):1059-67. PubMed ID: 21797939
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6 polymorphism and the presence of anti-LKM-1 in patients with chronic hepatitis C.
Hijikata M; Miyakawa H; Matsushita M; Kako M; Ohta Y; Mishiro S
Biochem Biophys Res Commun; 2000 Apr; 270(3):922-6. PubMed ID: 10772926
[TBL] [Abstract][Full Text] [Related]
12. SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C.
Romero-Gómez M; Montes-Cano MA; Otero-Fernández MA; Torres B; Sánchez-Muñoz D; Aguilar F; Barroso N; Gómez-Izquierdo L; Castellano-Megias VM; Núñez-Roldán A; Aguilar-Reina J; González-Escribano MF
Gut; 2004 Mar; 53(3):446-50. PubMed ID: 14960532
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels.
Besheer T; Arafa M; El-Maksoud MA; Elalfy H; Hasson A; Zalata K; Elkashef W; Elshahawy H; Raafat D; Elemshaty W; Elsayed E; Zaghloul H; Razek AA; El-Bendary M
Turk J Gastroenterol; 2018 May; 29(3):299-307. PubMed ID: 29755014
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2D6 polymorphism is a molecular genetic marker of liver cirrhosis progression.
Nepomnyashchikh DL; Vavilin VA; Aidagulova SV; Makarova SI; Karavaeva YY; Shchepotina EG; Postnikova OA; Nokhrina ZhV; Vinogradova EV; Lyakhovich VV
Bull Exp Biol Med; 2012 Mar; 152(5):633-6. PubMed ID: 22803153
[TBL] [Abstract][Full Text] [Related]
15. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.
Falleti E; Cmet S; Fabris C; Bitetto D; Cussigh A; Fornasiere E; Bignulin E; Feruglio C; Mosanghini E; Fontanini E; Pirisi M; Toniutto P
Cytokine; 2012 Jan; 57(1):68-73. PubMed ID: 22122913
[TBL] [Abstract][Full Text] [Related]
16. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
Marcolongo M; Young B; Dal Pero F; Fattovich G; Peraro L; Guido M; Sebastiani G; Palù G; Alberti A
Hepatology; 2009 Oct; 50(4):1038-44. PubMed ID: 19676127
[TBL] [Abstract][Full Text] [Related]
17. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
Trépo E; Pradat P; Potthoff A; Momozawa Y; Quertinmont E; Gustot T; Lemmers A; Berthillon P; Amininejad L; Chevallier M; Schlué J; Kreipe H; Devière J; Manns M; Trépo C; Sninsky J; Wedemeyer H; Franchimont D; Moreno C
Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.
Wang H; Mengsteab S; Tag CG; Gao CF; Hellerbrand C; Lammert F; Gressner AM; Weiskirchen R
World J Gastroenterol; 2005 Apr; 11(13):1929-36. PubMed ID: 15800982
[TBL] [Abstract][Full Text] [Related]
19. Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population.
Menoyo A; del Rio E; Baiget M
Cell Biochem Funct; 2006; 24(5):381-5. PubMed ID: 16130179
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.
Miyashita M; Ito T; Sakaki M; Kajiwara A; Nozawa H; Hiroishi K; Kobayashi M; Kumada H; Imawari M
J Viral Hepat; 2012 Sep; 19(9):608-14. PubMed ID: 22863264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
